Implication of oncogenic signaling pathways as a treatment strategy for neurodegenerative disorders - contemporary approaches

CNS and Neurological Disorders - Drug Targets

Volumn 10, Issue 2, 2011, Pages 271-294

  Sieradzki, Adrian ^a   Yendluri, Bharat B ^b   Palacios, Hector H ^b   Parvathaneni, Kalpana ^d   Reddy, V Prakash ^c   Obrenovich, Mark E ^d   Gasiorowski, Kazimierz ^a   Leszek, Jerzy ^a   Aliev, Gjumrakch ^e  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b University of San Antonio   (United States)

^c MISSOURI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (United States)

^d CLEVELAND STATE UNIVERSITY   (United States)

^e University of Atlanta   (United States)

Author keywords

Alzheimer's disease; Cell cycle; Mitochondria; Oncogenes; Parkinson's disease

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BRCA1 PROTEIN; DJ 1 PROTEIN; NUCLEOPORIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PRESENILIN; PROTEIN KINASE B; ONCOPROTEIN;

ALZHEIMER DISEASE; ARTICLE; CELL CYCLE REGULATION; DEGENERATIVE DISEASE; NEUROPROTECTION; ONCOGENE; OXIDATIVE STRESS; PARKINSON DISEASE; SIGNAL TRANSDUCTION; CELL CYCLE; HUMAN; METABOLISM; NERVE CELL; NERVE DEGENERATION; PATHOLOGY; REVIEW;

ALZHEIMER DISEASE; CELL CYCLE; HUMANS; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; NEURONS; NUCLEAR PORE COMPLEX PROTEINS; ONCOGENE PROTEINS; ONCOGENES; OXIDATIVE STRESS; PARKINSON DISEASE; SIGNAL TRANSDUCTION;

MLCS; MLOWN;

EID: 79551664640     PISSN: 18715273     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Andorfer, C.; Acker, C.M.; Kress, Y.; Hof, P.R.; Duff, K.; Davies, P. Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J. Neurosci., 2005, 25(22), 5446-5454.
2. Blalock, E.M.; Geddes, J.W.; Chen, K.C.; Porter, N.M.; Markesbery, W.R.; Landfield, P.W. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc. Natl. Acad. Sci. USA, 2004, 101(7), 2173-2178.
3. Causeret, F.; Terao, M.; Jacobs, T.; Nishimura, Y.V.; Yanagawa, Y.; Obata, K.; Hoshino, M.; Nikolic, M. The p21-activated kinase is required for neuronal migration in the cerebral cortex. Cereb. Cortex, 2009, 19(4), 861-875.
4. Kumar, R.; Gururaj, A.E.; Barnes, C.J. p21-activated kinases in cancer. Nat. Rev. Cancer, 2006, 6(6), 459-471.
5. Meng, J.; Meng, Y.; Hanna, A.; Janus, C.; Jia, Z. Abnormal longlasting synaptic plasticity and cognition in mice lacking the mental retardation gene Pak3. J. Neurosci., 2005, 25(28), 6641-6650.
6. Lee, H.G.; Casadesus, G.; Zhu, X.; Castellani, R.J.; McShea, A.; Perry, G.; Petersen, R.B.; Bajic, V.; Smith, M.A. Cell cycle reentry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease. Neurochem. Int., 2009, 54(2), 84-88.
7. Zhu, X.; Siedlak, S.L.; Wang, Y.; Perry, G.; Castellani, R.J.; Cohen, M.L.; Smith, M.A. Neuronal binucleation in Alzheimer disease hippocampus. Neuropathol. Appl. Neurobiol., 2008, 34(4), 457-465.
8. Woods, J.; Snape, M.; Smith, M.A. The cell cycle hypothesis of Alzheimer's disease: suggestions for drug development. Biochim. Biophys. Acta, 2007, 1772(4), 503-508.
9. McShea, A.; Lee, H.G.; Petersen, R.B.; Casadesus, G.; Vincent, I.; Linford, N.J.; Funk, J.O.; Shapiro, R.A.; Smith, M.A. Neuronal cell cycle re-entry mediates Alzheimer disease-type changes. Biochim. Biophys. Acta, 2007, 1772(4), 467-472.
10. Park, K.H.; Hallows, J.L.; Chakrabarty, P.; Davies, P.; Vincent, I. Conditional neuronal simian virus 40 T antigen expression induces Alzheimer-like tau and amyloid pathology in mice. J. Neurosci., 2007, 27(11), 2969-2978.
11. Ledoux, S.; Rebai, N.; Dagenais, A.; Shaw, I.T.; Nalbantoglu, J.; Sekaly, R.P.; Cashman, N.R. Amyloid precursor protein in peripheral mononuclear cells is up-regulated with cell activation. J. Immunol., 1993, 150(12), 5566-5575.
12. Suzuki, T.; Oishi, M.; Marshak, D.R.; Czernik, A.J.; Nairn, A.C.; Greengard, P. Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. EMBO J., 1994, 13(5), 1114-1122.
13. McDonald, D.R.; Bamberger, M.E.; Combs, C.K.; Landreth, G.E. beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J. Neurosci., 1998, 18(12), 4451-4460.
14. Giovanni, A.; Wirtz-Brugger, F.; Keramaris, E.; Slack, R.; Park, D.S. Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F x DP, in B-amyloid-induced neuronal death. J. Biol. Chem., 1999, 274(27), 19011-19016.
15. Mattson, M.P.; Guo, Q.; Furukawa, K.; Pedersen, W.A. Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease. J. Neurochem., 1998, 70(1), 1-14.
16. Malik, B.; Currais, A.; Andres, A.; Towlson, C.; Pitsi, D.; Nunes, A.; Niblock, M.; Cooper, J.; Hortobagyi, T.; Soriano, S. Loss of neuronal cell cycle control as a mechanism of neurodegeneration in the presenilin-1 Alzheimer's disease brain. Cell Cycle, 2008, 7(5), 637-646.
17. Cruz, J.C.; Kim, D.; Moy, L.Y.; Dobbin, M.M.; Sun, X.; Bronson, R.T.; Tsai, L.H. p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo. J. Neurosci., 2006, 26(41), 10536-10541.
18. Ding, Y.; Qiao, A.; Wang, Z.; Goodwin, J.S.; Lee, E.S.; Block, M.L.; Allsbrook, M.; McDonald, M.P.; Fan, G.H. Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model. J. Neurosci., 2008, 28(45), 11622-11634.
19. Korhonen, L.; Brännvall, K.; Skoglösa, Y.; Lindholm, D. Tumor suppressor gene BRCA-1 is expressed by embryonic and adult neural stem cells and involved in cell proliferation. J. Neurosci. Res., 2003, 71(6), 769-776.
20. Raina, A.K.; Zhu, X.; Rottkamp, C.A.; Monteiro, M.; Takeda, A.; Smith, M.A. Cyclin' toward dementia: cell cycle abnormalities and abortive oncogenesis in Alzheimer disease. J. Neurosci. Res., 2000, 61(2), 128-133.
21. McPherson, J.P.; Hande, M.P.; Poonepalli, A.; Lemmers, B.; Zablocki, E.; Migon, E.; Shehabeldin, A.; Porras, A.; Karaskova, J.; Vukovic, B.; Squire, J.; Hakem, R. A role for Brca1 in chromosome end maintenance. Hum. Mol. Genet., 2006, 15(6), 831-838.
22. Franco, S.; Blasco, M.A.; Siedlak, S.L.; Harris, P.L.; Moreira, P.I.; Perry, G.; Smith, M.A. Telomeres and telomerase in Alzheimer's disease: epiphenomena or a new focus for therapeutic strategy? Alzheimers Dement., 2006, 2(3), 164-168.
23. Evans, T.A.; Raina, A.K.; Delacourte, A.; Aprelikova, O.; Lee, H.G.; Zhu, X.; Perry, G.; Smith, M.A. BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease. Int. J. Med. Sci., 2007, 4(3), 140-145.
24. Clements, C.M.; McNally, R.S.; Conti, B.J.; Mak, T.W.; Ting, J.P. DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc. Natl. Acad. Sci. USA, 2006, 103(41), 15091-15096.
25. Kuroda, Y.; Mitsui, T.; Kunishige, M.; Shono, M.; Akaike, M.; Azuma, H.; Matsumoto, T. Parkin enhances mitochondrial biogenesis in proliferating cells. Hum. Mol. Genet., 2006, 15(6), 883-895.
26. Kim, R.H.; Smith, P.D.; Aleyasin, H.; Hayley, S.; Mount, M.P.; Pownall, S.; Wakeham, A.; You-Ten, A.J.; Kalia, S.K.; Horne, P.; Westaway, D.; Lozano, A.M.; Anisman, H.; Park, D.S.; Mak, T.W. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine(MPTP) and oxidative stress. Proc. Natl. Acad. Sci. USA, 2005, 102(14), 5215-5220.
27. Meulener, M.C.; Xu, K.; Thomson, L.; Ischiropoulos, H.; Bonini, N.M. Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging. Proc. Natl. Acad. Sci. USA, 2006, 103(33), 12517-12522.
28. Giaime, E.; Sunyach, C.; Druon, C.; Scarzello, S.; Robert, G.; Grosso, S.; Auberger, P.; Goldberg, M.S.; Shen, J.; Heutink, P.; Pouyssegur, J.; Pages, G.; Checler, F.; Alves da Costa, C. Loss of function of DJ-1 triggered by Parkinson's disease-associated mutation is due to proteolytic resistance to caspase-6. Cell Death Differ., 2010, 17(1), 158-169.
29. Kinumi, T.; Kimata, J.; Taira, T.; Ariga, H.; Niki, E. Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxidemediated oxidation in vivo in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun., 2004, 317(3), 722-728.
30. Inden, M.; Taira, T.; Kitamura, Y.; Yanagida, T.; Tsuchiya, D.; Takata, K.; Yanagisawa, D.; Nishimura, K.; Taniguchi, T.; Kiso, Y.; Yoshimoto, K.; Agatsuma, T.; Koide-Yoshida, S.; Iguchi-Ariga, S.M.; Shimohama, S.; Ariga, H. PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model. Neurobiol. Dis., 2006, 24(1), 144-158.
31. Zhou, W.; Zhu, M.; Wilson, M.A.; Petsko, G.A.; Fink, A.L. The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein. J. Mol. Biol., 2006, 356(4), 1036-1048.
32. Vasseur, S.; Afzal, S.; Tardivel-Lacombe, J.; Park, D.S.; Iovanna, J.L.; Mak, T.W. DJ-1/PARK7 is an important mediator of hypoxiainduced cellular responses. Proc. Natl. Acad. Sci. USA, 2009, 106(4), 1111-1116.
33. Gorner, K.; Holtorf, E.; Waak, J.; Pham, T.T.; Vogt-Weisenhorn, D.M.; Wurst, W.; Haass, C.; Kahle, P.J. Structural determinants of the C-terminal helix-kink-helix motif essential for protein stability and survival promoting activity of DJ-1. J. Biol. Chem., 2007, 282(18), 13680-13691.
34. Bretaud, S.; Allen, C.; Ingham, P.W.; Bandmann, O. p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson's disease. J. Neurochem., 2007, 100(6), 1626-1635.
35. Pisani, A.; Martella, G.; Tscherter, A.; Costa, C.; Mercuri, N.B.; Bernardi, G.; Shen, J.; Calabresi, P. Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K+ ATPase. Neurobiol. Dis., 2006, 23(1), 54-60.
36. Yang, Y.; Gehrke, S.; Haque, M.E.; Imai, Y.; Kosek, J.; Yang, L.; Beal, M.F.; Nishimura, I.; Wakamatsu, K.; Ito, S.; Takahashi, R.; Lu, B. Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc. Natl. Acad. Sci. USA, 2005, 102(38), 13670-13675.
37. Junn, E.; Taniguchi, H.; Jeong, B.S.; Zhao, X.; Ichijo, H.; Mouradian, M.M. Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proc. Natl. Acad. Sci. USA, 2005, 102(27), 9691-9696.
38. Zhong, N.; Kim, C.Y.; Rizzu, P.; Geula, C.; Porter, D.R.; Pothos, E.N.; Squitieri, F.; Heutink, P.; Xu, J. DJ-1 transcriptionally upregulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding protein-associated splicing factor. J. Biol. Chem., 2006, 281(30), 20940-20948.
39. Cully, M.; You, H.; Levine, A.J.; Mak, T.W. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev. Cancer, 2006, 6(3), 184-192.
40. Morris, L.G.; Veeriah, S.; Chan, T.A. Genetic determinants at the interface of cancer and neurodegenerative disease. Oncogene, 2010, 29(24), 3453-3464.
41. Zhu, Y.; Hoell, P.; Ahlemeyer, B.; Krieglstein, J. PTEN: a crucial mediator of mitochondria-dependent apoptosis. Apoptosis, 2006, 11(2), 197-207.
42. Maehama, T.; Taylor, G.S.; Dixon, J.E. PTEN and myotubularin: novel phosphoinositide phosphatases. Annu. Rev. Biochem., 2001, 70, 247-279.
43. Delgado-Esteban, M.; Martin-Zanca, D.; Andres-Martin, L.; Almeida, A.; Bolanos, J.P. Inhibition of PTEN by peroxynitrite activates the phosphoinositide-3-kinase/Akt neuroprotective signaling pathway. J. Neurochem., 2007, 102(1), 194-205.
44. Kim, R.H.; Mak, T.W. Tumours and tremors: how PTEN regulation underlies both. Br. J. Cancer, 2006, 94(5), 620-624.
45. Gautier, C.A.; Kitada, T.; Shen, J. Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc. Natl. Acad. Sci. USA, 2008, 105(32), 11364-11369.
46. Wei, W.; Wang, X.; Kusiak, J.W. Signaling events in amyloid betapeptide- induced neuronal death and insulin-like growth factor I protection. J. Biol. Chem., 2002, 277(20), 17649-17656.
47. Ries, V.; Henchcliffe, C.; Kareva, T.; Rzhetskaya, M.; Bland, R.; During, M.J.; Kholodilov, N.; Burke, R.E. Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease. Proc. Natl. Acad. Sci. USA, 2006, 103(49), 18757-18762.
48. Thomas, B.; Beal, M.F. Parkinson's disease. Hum. Mol. Genet., 2007, 16(Spec No.2), R183-R194.
49. Fallon, L.; Belanger, C.M.; Corera, A.T.; Kontogiannea, M.; Regan-Klapisz, E.; Moreau, F.; Voortman, J.; Haber, M.; Rouleau, G.; Thorarinsdottir, T.; Brice, A.; van Bergen En Henegouwen, P.M.; Fon, E.A. A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)KAkt signalling. Nat. Cell Biol., 2006, 8(8), 834-842.
50. Valente, E.M.; Abou-Sleiman, P.M.; Caputo, V.; Muqit, M.M.; Harvey, K.; Gispert, S.; Ali, Z.; Del Turco, D.; Bentivoglio, A.R.; Healy, D.G.; Albanese, A.; Nussbaum, R.; Gonzalez-Maldonado, R.; Deller, T.; Salvi, S.; Cortelli, P.; Gilks, W.P.; Latchman, D.S.; Harvey, R.J.; Dallapiccola, B.; Auburger, G.; Wood, N.W. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science, 2004, 304(5674), 1158-160.
51. Chen, H.K.; Fernandez-Funez, P.; Acevedo, S.F.; Lam, Y.C.; Kaytor, M.D.; Fernandez, M.H.; Aitken, A.; Skoulakis, E.M.; Orr, H.T.; Botas, J.; Zoghbi, H.Y. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell, 2003, 113(4), 457-468.
52. Rickle, A.; Bogdanovic, N.; Volkmann, I.; Zhou, X.; Pei, J.J.; Winblad, B.; Cowburn, R.F. PTEN levels in Alzheimer's disease medial temporal cortex. Neurochem. Int., 2006, 48(2), 114-123.
53. Griffin, R.J.; Moloney, A.; Kelliher, M.; Johnston, J.A.; Ravid, R.; Dockery, P.; O'Connor, R.; O'Neill, C. Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. J. Neurochem., 2005, 93(1), 105-117.
54. D'Angelo, M.A.; Raices, M.; Panowski, S.H.; Hetzer, M.W. Agedependent deterioration of nuclear pore complexes causes a loss of nuclear integrity in postmitotic cells. Cell, 2009, 136(2), 284-295.
55. Kotwaliwale, C.V.; Dernburg, A.F. Old nuclei spring new leaks. Cell, 2009, 136(2), 211-212.
56. Crampton, N.; Kodiha, M.; Shrivastava, S.; Umar, R.; Stochaj, U. Oxidative stress inhibits nuclear protein export by multiple mechanisms that target FG nucleoporins and Crm1. Mol. Biol. Cell, 2009, 20(24), 5106-5116.
57. Zhu, X.; Lee, H.G.; Perry, G.; Smith, M.A. Alzheimer disease, the two-hit hypothesis: an update. Biochim. Biophys. Acta, 2007, 1772(4), 494-502.
58. Wang, W.; Bu, B.; Xie, M.; Zhang, M.; Yu, Z.; Tao, D. Neural cell cycle dysregulation and central nervous system diseases. Prog. Neurobiol., 2009, 89(1), 1-17.
59. Klein, J.A.; Ackerman, S.L. Oxidative stress, cell cycle, and neurodegeneration. J. Clin. Invest., 2003, 111(6), 785-793.
60. Vincent, I.; Jicha, G.; Rosado, M.; Dickson, D.W. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J. Neurosci., 1997, 17(10), 3588-3598.
61. Bonda, D.J.; Bajic, V.P.; Spremo-Potparevic, B.; Casadesus, G.; Zhu, X.; Smith, M.A.; Lee, H.G. Review: cell cycle aberrations and neurodegeneration. Neuropathol. Appl. Neurobiol., 2010, 36(2), 157-163.
62. Konishi, Y.; Lehtinen, M.; Donovan, N.; Bonni, A. Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery. Mol. Cell, 2002, 9(5), 1005-1016.
63. Wang, X.; Su, B.; Fujioka, H.; Zhu, X. Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients. Am. J. Pathol., 2008, 173(2), 470-482.
64. Nunomura, A.; Perry, G.; Aliev, G.; Hirai, K.; Takeda, A.; Balraj, E.K.; Jones, P.K.; Ghanbari, H.; Wataya, T.; Shimohama, S.; Chiba, S.; Atwood, C.S.; Petersen, R.B.; Smith, M.A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol., 2001, 60(8), 759-767.
65. Hirai, K.; Aliev, G.; Nunomura, A.; Fujioka, H.; Russell, R.L.; Atwood, C.S.; Johnson, A.B.; Kress, Y.; Vinters, H.V.; Tabaton, M.; Shimohama, S.; Cash, A.D.; Siedlak, S.L.; Harris, P.L.; Jones, P.K.; Petersen, R.B.; Perry, G.; Smith, M.A. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci., 2001, 21(9), 3017-3023.
66. Zhu, X.; Raina, A.K.; Rottkamp, C.A.; Aliev, G.; Perry, G.; Boux, H.; Smith, M.A. Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J. Neurochem., 2001, 76(2), 435-441.